GLP-1R is present in the human pancreas, several brain regions responsible for appetite, satiety, and food intake-energy balance, and the gastrointestinal tract (3638)
Let's look at some of the common physical side effects of each medication
Highlights Sodium-glucose cotransporter-2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) provide modest but clinically meaningful blood pressure (BP) lowering effects in people with hypertension and cardiometabolic comorbidities
These differences may influence how strongly each drug affects central reward pathways
I am so glad that my doctor sat me down and told me what to expect
Inhibition oF DPP-4 activity and bone metabolism Some studies have shown that greater DPP-4 levels or activity correlate with decreased BMD as well as increased bone resorption markers, risk of fractures, and inflammatory markers ( e.g